Altimmune (MEX:ALT1) Total Tax Payable : MXN0.00 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Altimmune Total Tax Payable?

Altimmune's Total Tax Payable for the quarter that ended in Sep. 2024 was MXN0.00 Mil.

Altimmune's annual Total Tax Payable increased from Dec. 2021 (MXN0.00 Mil) to Dec. 2022 (MXN22.79 Mil) but then declined from Dec. 2022 (MXN22.79 Mil) to Dec. 2023 (MXN0.00 Mil).

Altimmune Total Tax Payable Historical Data

The historical data trend for Altimmune's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Altimmune Total Tax Payable Chart

Altimmune Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

22.79

Altimmune Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

Altimmune Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Altimmune Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Altimmune's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Altimmune Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (MEX:ALT1) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

ALT:USA 0A4C:UK 3G0:Germany 3G0:Germany

Address

910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878

Website

https://www.altimmune.com

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Altimmune Headlines

No Headlines